Modeling the MYC-driven normal-to-tumour switch in breast cancer.
C. Lourenco, M. Kalkat, K. E. Houlahan, J. De Melo, J. Longo, S. J. Done, P. C. Boutros, L. Z. Penn
This study creates an in vivo model of MYC-driven breast cancer by combining PIK3CAH1047R mutation with deregulated MYC, showing a normal-to-tumour switch and dependence on MYC for tumor growth.
bioRxiv · Aug 20, 2018Cancer Biology